News
India’s Cervavac HPV Vaccine Gets WHO Prequalification, Paving Way For Global Distribution To Prevent HPV-Related Diseases
Summary by The Mumbai Editorial Desk Free Press Journal
· October 5, 2026
· 1 min read
Photo: Free Press Journal · view original
Story provenance No corrections
Summary created by The Mumbai Editorial Desk — automated, rule-governed Published by Free Press Journal Original story Read at the source Source published Oct 5, 2026 Indexed here Oct 5, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points This vaccine is designed to prevent diseases related to a specific virus and can be used in individuals from 9 to 26 years old. A significant regulatory milestone has been achieved with the prequalification of a vaccine by the World Health Organisation.
A significant regulatory milestone has been achieved with the prequalification of a vaccine by the World Health Organisation. This vaccine is designed to prevent diseases related to a specific virus and can be used in individuals from 9 to 26 years old. The manufacturer has received numerous prequalifications from the World Health Organisation in the past.
The prequalified vaccine targets several strains of the virus and is intended for use in both girls and boys.
Further details about this development are available from the source publication, including information about the vaccine's manufacturer and its potential for global distribution.
More News Today’s briefing Local events
Why this story is here
Free Press Journal reported and published this story. The Mumbai selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by Free Press Journal . The Mumbai selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Free Press Journal . Have a tip or correction? Contact the editor .
Category: News Published: October 5, 2026 Source: Free Press Journal Reading time: 1 min
Frequently asked about this story
What is this story about? A significant regulatory milestone has been achieved with the prequalification of a vaccine by the World Health Organisation. This vaccine is designed to prevent diseases related to a specific virus…
When was this published? This article was first published on October 5, 2026 by Free Press Journal and curated for The Mumbai readers.
Who reported this story? This story was reported by Free Press Journal. To learn more about how The Mumbai selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Mumbai, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
